digitalhealth,generativeAI,medicaldevices

Mashup Score: 0

4 takeaways from the FDA’s first digital health advisory committee - 8 hour(s) ago

Industry and patient representatives debated how the FDA should regulate generative AI in medical devices and address new challenges with the technology, such as the use of complex models that can change quickly.

Source: www.medtechdive.com

Categories: General Medicine News, General HCPs

Tweet Tweets with this article
- Sid_Healthcare
  
  4 takeaways from the FDA’s first #digitalhealth advisory committee - Industry and patient representatives debated how the FDA should regulate #generativeAI in #medicaldevices and address new challenges with the technology. https://t.co/3ki76IVx1E